To Get Help Now
Click Here
 
Today's Date:

Pfizer to Pay $72 Million in Prempro Breast Cancer Lawsuit

AddThis Social Bookmark Button

Jurors deliberated for two days before deciding that the menopause hormone-replacement drug Prempro caused Susan Elfont, Bernadette Kalenkoski, and Judy Mulderig to develop breast cancer. The Philadelphia jury awarded Elfont $20 million in compensatory damages, Kalenkoski, $27.85 million, and Mulderig, $24.75 million, Bloomberg reported.

Prempro is a combination of estrogen and progestin and manufactured by Pfizer’s Wyeth and Pharmacia Upjohn units. Over 6 million women have used Prempro to relieve the symptoms of menopause, including hot flashes and mood swings. However, in 2002, the Women’s Health Initiative released a National Institutes of Health sponsored study that showed the drug was linked to cancer.

So far, Pfizer has lost 10 of the 18 Prempro lawsuits heard since 2006. Pfizer announced earlier this year that one-third of Prempro cases pending had been settled, and that the company had set aside $772 million to resolve the claims.

The second phase of the Elfont, Kalenkoski, and Mulderig case is slated to begin tomorrow, when the jury will consider Wyeth’s liability for damages.

Bloomberg reported that Chris Loder, a Pfizer spokesperson said, “We are obviously disappointed with the verdict in this case,” in a written statement. “Once the verdict is finalized, the company will weigh its legal options to determine how it will continue with the case.”

 

 

breakinglawsuitnews.com disclaimer: This article: Pfizer to Pay $72 Million in Prempro Breast Cancer Lawsuit was posted on Thursday, December 8th, 2011 at 8:09 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Comments are closed.